Mycophenolate mofetil for autoimmune cytopenias in children: high rates of response in inborn errors of immunity

Mycophenolate mofetil for autoimmune cytopenias in children: high rates of response in inborn errors of immunity

Second-line treatments of autoimmune cytopenias (AC) are not well-defined in children. Mycophenolate mofetil (MMF) is an immunosuppressant agent that has been demonstrated to be safe and effective in this setting. A retrospective observational study was conducted in 18 children with prolonged AC who...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubén Berrueco, Elisa González-Forster, Angela Deya-Martinez, María Solsona, Ana García-García, Joan Calzada-Hernández, Luo Yiyi, Alexandru Vlagea, Anna Ruiz-Llobet, Laia Alsina
Formato: Artículo
Lenguaje:English
Publicado: Frontiers Media S.A. 2023-10-01
Colección:Frontiers in Pediatrics
Materias:
pediatrics
autoimmune hemolytic anemia
autoimmune thrombocytopenia
Evans syndrome
autoimmune diseases
mycophenolate mofetil
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fped.2023.1174671/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2023.1174671/full

Ejemplares similares